Table 1.
NP or PA | Rheumatologist only | p-values | |
---|---|---|---|
N patients | 158 | 143 | |
N visits | 1168 | 814 | |
N rheumatologists | 7 | 7 | |
N of NPs or PAs | 6 | NA | |
| |||
Visits per patients, mean (SD)* | 7.4 (2.6) | 5.7 (1.9) | <.0001 |
| |||
Seen by mid-level provider only | 723 (61.9%) | -- | |
Seen by rheumatologist only | 320 (27.4%) | 814 (100.0%) | |
Seen by both providers | 125 (10.7%) | -- | |
Female sex | 126 (80%) | 106 (74%) | 0.27 |
| |||
Disease duration | |||
| |||
<2 years | 17 (11.0%) | 12 (8.8%) | 0.27 |
2–5 years | 20 (13.0%) | 13 (9.6%) | |
5–10 years | 42 (27.3%) | 29 (21.3%) | |
10+ years | 75 (48.7%) | 82 (60.3%) | |
Missing | 4 (2.5%) | 7 (4.9%) | |
Seropositive, n (%) | 76 (68.5%) | 67 (69.8%) | 0.07 |
| |||
Disease activity at first visit | 0.08 | ||
| |||
Remission | 29 (32.9%) | 33 (28.7%) | |
Low | 27 (30.7%) | 26 (22.6%) | |
Moderate | 24 (27.3%) | 35 (30.4%) | |
High | 8 (9.1%) | 24 (18.3%) |
NP, nurse practitioner; PA, physician assistant; SD, standard deviation. Seropositive refers to rheumatoid factor or anti-CCP antibody. This variable had 34% missing for patients seen at practices with mid-level providers and 32% missing for the other practices.
In the NP/PA group: average visits by provider were as follows: 4.6 NP or PA only, 2.0 rheumatologist only, and 0.8 to both.